EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›BVFL

BVFL

BV Financial, Inc.

Next earnings Jul 15, 2026

Last earnings +1.2% on 2026-04-24

Hold
$21.64
▲ +1.45%
$21.64▲ +42.74%
over 1Y
L $14.63EODHDH $21.83
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.5%
1W+0.1%
1M+9.4%
3M+10.9%
YTD+19.1%
1Y+42.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Undervalued
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••

Overcapitalized post-conversion thrift buying back stock hard at ~1x book — cheap and stable, but 7.3% ROE and flat assets cap the upside.

Diluted EPS $1.43 · FY2025

The read

Middling fundamentals offset by an attractive price (~85% below fair value) — worth a look on the value angle.

BVFL is a small Maryland-chartered savings institution behaving exactly like a recently-converted, capital-heavy thrift: total assets are dead flat YoY ($912M, +0.0%) and stockholders' equity actually shrank 6% to $184M — not from losses but from an aggressive $30.0M of buybacks (up 69.6%) that retired 17.4% of the share count. That capital return is the whole EPS story. Net income rose a respectable 15.1% to $13.5M, but diluted EPS jumped 31.2% to $1.43 almost entirely because the denominator collapsed. Look through the buyback and the underlying franchise is only modestly profitable: return on equity is just 7.3%, weak for a bank and a sign the balance sheet is over-equitized (liabilities/equity of 3.96x is low leverage for a depository). Net income is also lumpy, not compounding — $10.5M → $13.7M → $11.7M → $13.5M over FY2022–2025.

On valuation the setup is reasonable but not cheap enough to demand ownership. At $21.64 the stock trades at 15.1x FY EPS and roughly 1.0x book value (equity of $184M over 8.75M shares is ~$21/share). For a 7.3%-ROE bank, ~1x tangible book and mid-teens earnings is a fair price, not a bargain. The redeeming feature is that management is buying stock at around book — accretive, and a rational use of excess capital when organic asset growth is absent. Operating cash flow of $19.0M (+18.4%) comfortably funds the tiny $237K capex and the buyback, and long-term debt was cut 29.8% to $35.0M, so the capital return is not being levered up.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25
Revenue————
Gross profit————
Operating income————
Net income$10.5M$13.7M$11.7M$13.5M
Diluted EPS$1.32$1.47$1.09$1.43
Net margin————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF10.0
PEG (trailing)1.00
Earnings yield7.2%
FCF yield10.0%

Quality & risk

ROIC (est.)—
Free cash flow$18.8M
Total debt$35.0M
Net cash$20.7M
Piotroski F-Score6/6

Capital returns

Buyback yield16.0%
Dividend yield (est.)—
Shareholder yield16.0%
Shares Δ YoY-17.4%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Other event2026-06-01

    Item 8.01 other-events notice — corporate update, no direct earnings impact stated

  2. 10-Q Quarterly report2026-05-11

    Q1 2026 10-Q: profitability intact; buybacks cut shares ~17% YoY; CRE 53% of loans

  3. 8-K Shareholder vote2026-05-08

    Item 5.07: annual meeting voting results — directors/proposals ratified

  4. 8-K Other event2026-05-06

    Item 8.01 other-events disclosure (likely capital/buyback or dividend update)

  5. 8-K Earnings results2026-04-24

    Q1 2026 earnings furnished (Item 2.02); results released with exhibits

  6. DEF 14A Proxy statement2026-04-02

    2026 proxy: director elections, exec comp and auditor ratification

  7. 10-K Annual report2026-03-27

    FY2025 10-K: NI $13.5M, EPS $1.43 (+31%), $30M buybacks; CRE 53% of loans

  8. 8-K Auditor change2026-02-23

    Item 4.01: change in certifying accountant — auditor switch disclosed

  9. 8-K Earnings results2026-01-23

    FY2025 results: net income $13.5M (+15%), diluted EPS $1.43 (+31%)

Recent filings

all on EDGAR ↗
NT 11-KPeriod ending 2025-12-312026-06-30open ↗4Period ending 2026-06-112026-06-15open ↗4Period ending 2026-06-102026-06-11open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-052026-06-08open ↗4Period ending 2026-06-022026-06-04open ↗8-KPeriod ending 2026-06-012026-06-01open ↗144Filing2026-06-01open ↗4Period ending 2026-05-282026-05-29open ↗4Period ending 2026-05-272026-05-29open ↗4Period ending 2026-05-262026-05-27open ↗144Filing2026-05-26open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueB+
GrowthA-
ProfitabilityC
Financial healthA-
MomentumA
  • ✓Profitable (positive net income)
  • ✗Return on equity above 15%
  • ✓P/E below 25

Fair value est.

$40.12

Undervalued +85% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.43 × (8.5 + 1.5 × 15.1% growth) × 0.90 quality = 28.1× multiple. An estimate, not a price target.

14.6352-week21.83
Revenue
—
Net margin
—
ROE
7.3%
P/E
15.1

SEC fundamentals · FY 2025

'22'23'24'25

■ revenue · ■ net income, by fiscal year

Net income$13.5M+15.1%
Diluted EPS$1.43+31.2%
Cash & equivalents$55.7M-21.0%
Total assets$912M+0.0%
Total liabilities$728M+1.7%
Stockholders' equity$184M-6.0%
L/E: 3.96x

Frequently asked

Is BV Financial, Inc. (BVFL) a buy?
BVFL currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Overcapitalized post-conversion thrift buying back stock hard at ~1x book — cheap and stable, but 7.3% ROE and flat assets cap the upside.
What is BVFL's fair value?
A Modified-Graham model based on BVFL's SEC fundamentals estimates a fair value of about $40.12. It is an estimate from reported earnings, not a price target.
Is BVFL overvalued or undervalued?
Against a Modified-Graham fair-value estimate, BVFL currently appears undervalued relative to its SEC-grounded earnings power.
What is BV Financial, Inc.'s quality score?
BVFL scores 74.7909194796062/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001302387, latest 10-Q filed 2026-05-11) · EODHD · Proprietary analysis · as of 7/3/2026, 3:31:13 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 54 sales

2026-06-12
Galli Joseph S
Director
Sell579.00 @ $19.80$11.5K
2026-06-12
Galli Joseph S
Director
Sell2.01K @ $19.81$39.9K
2026-06-12
Galli Joseph S
Director
Sell100.00 @ $19.82$1.98K
2026-06-12
Galli Joseph S
Director
Sell30.00 @ $19.84$595.20
2026-06-12
Galli Joseph S
Director
Sell2.00 @ $19.86$39.71
2026-06-12
Galli Joseph S
Director
Sell64.00 @ $19.88$1.27K
2026-06-12
Galli Joseph S
Director
Sell291.00 @ $19.96$5.81K
2026-06-11
Galli Joseph S
Director
Sell8.12K @ $19.84$161K
2026-06-10
Galli Joseph S
Director
Sell1.18K @ $19.75$23.2K
2026-06-10
Galli Joseph S
Director
Sell284.00 @ $19.76$5.61K
2026-06-10
Galli Joseph S
Director
Sell24.00 @ $19.77$474.36
2026-06-10
Galli Joseph S
Director
Sell316.00 @ $19.77$6.25K

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2018-12-28
Last amount
$0.03
ex 2018-12-28paid 2019-01-07$0.03
ex 2018-10-30paid 2018-11-07$0.03
ex 2018-08-07paid 2018-08-15$0.03
ex 2010-03-03paid 2010-03-25$0.03
ex 2009-12-04paid 2009-12-29$0.03
ex 2009-09-02paid 2009-09-24$0.03

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-24—▲ +1.20%8-K ↗
2026-01-23—▼ -0.84%8-K ↗
2025-10-20—▲ +7.96%8-K ↗
2025-07-18—▲ +0.51%8-K ↗
2025-04-18—▲ +3.07%8-K ↗
2025-01-28—▼ -1.67%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
The Zacks Analyst Blog Highlights AstraZeneca, HSBC, Walt Disney, Oak Valley Bancorp and BV FinancialBullish
finance.yahoo.com· 2026-04-08
Top Research Reports for AstraZeneca, HSBC & Walt DisneyBullish
finance.yahoo.com· 2026-04-07
BV Financial's Q4 Earnings Soar Y/Y on Credit Loss RecoveryBullish
finance.yahoo.com· 2026-01-29
The Zacks Analyst Blog Highlights Walmart, Intuitive Surgical, Lam Research and BV FinancialBullish
finance.yahoo.com· 2025-11-20
Top Stock Reports for Walmart, Intuitive Surgical & Lam ResearchBullish
finance.yahoo.com· 2025-11-19
3 Finance Stocks to Sell Before the Next Banking CrisisBearish
finance.yahoo.com· 2024-04-04

Vs tracked universe

compare →

1196 tracked peers · median

EDGAR Score75 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity7.3% vs 12.0%
P/E15.1 vs 26.2